News
The U.S. Food and Drug Administration gave Capricor Therapeutics' application on deramiocel priority review, with a decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback